News|Articles|January 23, 2024
Inhaled Biologics from Zero
Author(s)Experic
Experic’s latest article looks at new initiatives aimed at fostering the development of biologics delivered via inhalation, an emerging field. While manufacturing technologies have advanced to support this sector, several challenges remain, including an unclear regulatory pathway.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
EMA Calls New EU Pharma Legislation Most Significant in Two Decades
2
FDA’s CNPV Pilot Gives First Approval to Antibiotic for Pneumonia and Sinusitis
3
European Parliament Revamps Pharmaceutical Policy Framework
4
Optimizing Pharmaceutical Manufacturing Efficiency
5
